Plain-English translation of NCT05766449 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This is an observational study enrolling 1,000 patients with two liver conditions: chronic hepatitis B and non-alcoholic fatty liver disease (NAFLD). Researchers want to understand what factors increase the risk of serious liver damage โ like cirrhosis, liver cancer, or liver failure โ in people who have both conditions. By studying this population carefully, they hope to develop better tools to predict who is at highest risk and needs the most aggressive treatment.
When someone has both chronic hepatitis B and fatty liver disease at the same time, their liver damage often progresses faster and more severely than with either condition alone. Doctors currently lack clear guidance about which patients are most at risk and how to best monitor and treat them. This study aims to fill that gap by identifying the key warning signs and risk factors.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
As a participant, you would share your medical history, imaging results, and blood test data with the research team across multiple hospital centers in China. The study is observational, meaning researchers will track and analyze your existing medical information rather than asking you to take a new medication or undergo new procedures. Your involvement helps doctors understand patterns in how these two liver conditions interact and progress over time.
AI-generated summary from trial data ยท Jun 15, 2026 ยท Not medical advice
China